zepbound eli lilly news - Search News

Eli Lilly, food and drug administration

Fast Company · 18h

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

Barron's on MSN · 1d

Eli Lilly’s Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers.

Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list. Shares of Hims & Hers, which had capitalized on the pinch, are tumbling.

The Washington Post · 18h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

ConsumerAffairs19h

Mountjaro, Zepbound removed from FDA's shortage list

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Obesity Drug Shortage Ends for Lilly, Continues for Novo as Industry Bolsters Manufacturing

Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...

22m

Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

18h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results